Sutro Biopharma (STRO) Net Margin (2017 - 2026)
Sutro Biopharma's Net Margin was -391.64% in Q2 2026, down 373.60 percentage points from -18.04% a year earlier.
Powered by 
Analysis
Sutro Biopharma (STRO) Net Margin (2017 - 2026) Analysis & Trends
On a trailing twelve-month basis, Sutro Biopharma's Net Margin was -161.87% through Jun 30, 2026, up 37.89 percentage points year-over-year; for FY2025, it came in at -186.45%, up 180.16 percentage points from FY2024.
- Net Margin shows a five-year change of -111.25 percentage points (FY2020 to FY2025).
- In earlier years, Net Margin was -366.62% in FY2024 (-297.15 pp), -69.47% in FY2023 (+106.42 pp), -175.89% in FY2022 (-5.34 pp) and -170.55% in FY2021 (-95.35 pp).
- Quarterly Net Margin has moved between -663.22% (Q1 2022) and 27.32% (Q4 2023) over five years.
- Compared with a year earlier, Net Margin was higher in three of the last seven quarters, with an average year-over-year change of -131.16 percentage points.
- The best year-over-year quarter for Net Margin over five years was Q4 2023 (a gain of 428.08 percentage points); the worst was Q4 2024 (a drop of 516.50 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 26.44% |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 0.83% |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 24.24% |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 28.01% |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 20.69% |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 37.28% |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 29.27% |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 19.55% |
| 10 | Sutro Biopharma | 175.16 Mn | -500.76 Mn | - | -391.64% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -391.64% |
| Dec 31, 2025 | -401.49% |
| Sep 30, 2025 | -586.58% |
| Jun 30, 2025 | -18.04% |
| Mar 31, 2025 | -436.62% |
| Dec 31, 2024 | -489.18% |
| Sep 30, 2024 | -572.62% |
| Jun 30, 2024 | -186.80% |
| Mar 31, 2024 | -447.52% |
| Dec 31, 2023 | 27.32% |
| Sep 30, 2023 | -291.21% |
| Jun 30, 2023 | -370.00% |
| Mar 31, 2023 | -394.90% |
| Dec 31, 2022 | -400.76% |
| Sep 30, 2022 | -77.50% |
| Jun 30, 2022 | -92.58% |
| Mar 31, 2022 | -663.22% |
| Dec 31, 2021 | -357.85% |
| Sep 30, 2021 | -362.83% |
| Jun 30, 2021 | -21.93% |
API Access
Sutro Biopharma Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=STRO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "STRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=STRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();